ARV Stock Overview
Arvida Group Limited, together with its subsidiaries, owns, develops, and operates retirement villages and care facilities for the elderly in New Zealand.
+ 1 more risk
Arvida Group Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||NZ$1.81|
|52 Week High||NZ$2.15|
|52 Week Low||NZ$1.63|
|1 Month Change||-7.18%|
|3 Month Change||-10.84%|
|1 Year Change||4.62%|
|3 Year Change||36.09%|
|5 Year Change||33.09%|
|Change since IPO||90.53%|
Recent News & Updates
Does Arvida Group (NZSE:ARV) Deserve A Spot On Your Watchlist?
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
|ARV||NZ Healthcare||NZ Market|
Return vs Industry: ARV exceeded the NZ Healthcare industry which returned -4.1% over the past year.
Return vs Market: ARV exceeded the NZ Market which returned -11.4% over the past year.
|ARV Average Weekly Movement||2.9%|
|Healthcare Industry Average Movement||3.5%|
|Market Average Movement||3.8%|
|10% most volatile stocks in NZ Market||6.5%|
|10% least volatile stocks in NZ Market||2.4%|
Stable Share Price: ARV is less volatile than 75% of NZ stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: ARV's weekly volatility (3%) has been stable over the past year.
About the Company
Arvida Group Limited, together with its subsidiaries, owns, develops, and operates retirement villages and care facilities for the elderly in New Zealand. As of March 31, 2021, it operated approximately 33 retirement villages with 1,672 aged care beds and 2,695 retirement units. The company was formerly known as Hercules Limited.
Arvida Group Fundamentals Summary
|ARV fundamental statistics|
Is ARV overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ARV income statement (TTM)|
|Cost of Revenue||NZ$124.52m|
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
|Earnings per share (EPS)||0.23|
|Net Profit Margin||90.43%|
How did ARV perform over the long term?See historical performance and comparison
2.8%Current Dividend Yield
Is Arvida Group undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: ARV (NZ$1.81) is trading above our estimate of fair value (NZ$1.61)
Significantly Below Fair Value: ARV is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: ARV is good value based on its PE Ratio (7.9x) compared to the Oceanic Healthcare industry average (26.6x).
PE vs Market: ARV is good value based on its PE Ratio (7.9x) compared to the NZ market (17.6x).
Price to Earnings Growth Ratio
PEG Ratio: ARV's earnings are forecast to decline next year, so we can't calculate its PEG ratio.
Price to Book Ratio
PB vs Industry: ARV is good value based on its PB Ratio (1.5x) compared to the XO Healthcare industry average (2.7x).
How is Arvida Group forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ARV's earnings are forecast to decline over the next 3 years (-3.2% per year).
Earnings vs Market: ARV's earnings are forecast to decline over the next 3 years (-3.2% per year).
High Growth Earnings: ARV's earnings are forecast to decline over the next 3 years.
Revenue vs Market: ARV's revenue (11.4% per year) is forecast to grow faster than the NZ market (4.8% per year).
High Growth Revenue: ARV's revenue (11.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ARV's Return on Equity is forecast to be low in 3 years time (8.3%).
How has Arvida Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ARV has a large one-off gain of NZ$152.1M impacting its September 30 2021 financial results.
Growing Profit Margin: ARV's current net profit margins (90.4%) are higher than last year (23.2%).
Past Earnings Growth Analysis
Earnings Trend: ARV's earnings have grown significantly by 21.5% per year over the past 5 years.
Accelerating Growth: ARV's earnings growth over the past year (317.5%) exceeds its 5-year average (21.5% per year).
Earnings vs Industry: ARV earnings growth over the past year (317.5%) exceeded the Healthcare industry 70.4%.
Return on Equity
High ROE: ARV's Return on Equity (18.4%) is considered low.
How is Arvida Group's financial position?
Financial Position Analysis
Short Term Liabilities: ARV's short term assets (NZ$58.1M) exceed its short term liabilities (NZ$44.1M).
Long Term Liabilities: ARV's short term assets (NZ$58.1M) do not cover its long term liabilities (NZ$1.4B).
Debt to Equity History and Analysis
Debt Level: ARV's net debt to equity ratio (43.9%) is considered high.
Reducing Debt: ARV's debt to equity ratio has increased from 11.5% to 45.1% over the past 5 years.
Debt Coverage: ARV's debt is well covered by operating cash flow (36.5%).
Interest Coverage: ARV's interest payments on its debt are not well covered by EBIT (2.3x coverage).
What is Arvida Group current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: ARV's dividend (2.76%) is higher than the bottom 25% of dividend payers in the NZ market (2.76%).
High Dividend: ARV's dividend (2.76%) is low compared to the top 25% of dividend payers in the NZ market (4.97%).
Stability and Growth of Payments
Stable Dividend: Whilst dividend payments have been stable, ARV has been paying a dividend for less than 10 years.
Growing Dividend: ARV's dividend payments have increased, but the company has only paid a dividend for 7 years.
Current Payout to Shareholders
Dividend Coverage: With its low payout ratio (17.9%), ARV's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: ARV's dividends in 3 years are forecast to be well covered by earnings (43.4% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Mr. Jeremy Nicoll, BCom, CA serves as Chief Executive Officer at Arvida Group Limited since 2021 and was Deputy Chief Executive Officer until 2021. He served as the Chief Financial Officer of Arvida Grou...
Experienced Board: ARV's board of directors are considered experienced (6.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 32.7%.
Arvida Group Limited's employee growth, exchange listings and data sources
- Name: Arvida Group Limited
- Ticker: ARV
- Exchange: NZSE
- Founded: 2014
- Industry: Health Care Facilities
- Sector: Healthcare
- Implied Market Cap: NZ$1.303b
- Shares outstanding: 720.06m
- Website: https://www.arvida.co.nz
Number of Employees
- Arvida Group Limited
- 39 Market Place
- Level 1
- New Zealand
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/01/22 06:01|
|End of Day Share Price||2022/01/21 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.